Hu Haiyun – Trademark Portfolio

Entity Type: 01

Hu Haiyun holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include BROKNIT, CAGICAL, CANLIST, CINMOSE, and KAIR PEVIN. The owner is based in Wuhu, Anhui.

No. 85, Zhang Village, Jinghe Village

Yijiang Town, Nanling County

Wuhu, Anhui 241000 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BROKNIT
BROKNIT
Registered 2020
CAGICAL
CAGICAL
Registered 2020
CANLIST
CANLIST
Registered 2020
CINMOSE
CINMOSE
Registered 2020

Trademark Classifications

Hu Haiyun's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Hu Haiyun have?

Hu Haiyun has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does Hu Haiyun file in?

Hu Haiyun files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Hu Haiyun's most well-known trademarks?

Hu Haiyun's registered trademark portfolio includes well-known marks such as BROKNIT, CAGICAL, CANLIST, CINMOSE, and KAIR PEVIN. These are among 5 currently registered trademarks in the portfolio.

What is Hu Haiyun's trademark registration success rate?

Hu Haiyun has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.